DEVELOPMENT OF A SAFER NEW TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS THAT PRESERVES B CELL IMMUNITY

Grant number: 1113659 | Funding period: 2016 - 2018

Completed

Abstract

Lupus is an illness characterized by the body’s immune system attacking the body itself. More than 5 millions of people worldwide suffer from lupus, in particular Indigenous Australians who are 4 times more likely to develop lupus. Current treatments are toxic and/or lack efficacy. In this proposal we use strong new evidence from the laboratory to support the design of a much safer and more effective treatment for lupus that will be validated for future use in patients.